LeMaitre Vascular, Inc. (LMAT)
78.87
-0.60
(-0.76%)
USD |
NASDAQ |
Sep 18, 16:00
78.76
-0.11
(-0.14%)
After-Hours: 20:00
LeMaitre Vascular Enterprise Value : 1.617B for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.617B |
| September 17, 2026 | 1.631B |
| September 16, 2026 | 1.652B |
| September 15, 2026 | 1.649B |
| September 14, 2026 | 1.661B |
| September 11, 2026 | 1.657B |
| September 10, 2026 | 1.616B |
| September 09, 2026 | 1.631B |
| September 08, 2026 | 1.634B |
| September 04, 2026 | 1.659B |
| September 03, 2026 | 1.654B |
| September 02, 2026 | 1.683B |
| September 01, 2026 | 1.668B |
| August 31, 2026 | 1.650B |
| August 28, 2026 | 1.653B |
| August 27, 2026 | 1.636B |
| August 26, 2026 | 1.634B |
| August 25, 2026 | 1.620B |
| August 24, 2026 | 1.642B |
| August 21, 2026 | 1.686B |
| August 20, 2026 | 1.696B |
| August 19, 2026 | 1.732B |
| August 18, 2026 | 1.678B |
| August 17, 2026 | 1.701B |
| August 14, 2026 | 1.698B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.687B |
| August 12, 2026 | 1.692B |
| August 11, 2026 | 1.708B |
| August 10, 2026 | 1.670B |
| August 07, 2026 | 1.676B |
| August 06, 2026 | 1.662B |
| August 05, 2026 | 1.620B |
| August 04, 2026 | 2.233B |
| August 03, 2026 | 2.183B |
| July 31, 2026 | 2.131B |
| July 30, 2026 | 2.151B |
| July 29, 2026 | 2.182B |
| July 28, 2026 | 2.153B |
| July 27, 2026 | 2.076B |
| July 24, 2026 | 2.000B |
| July 23, 2026 | 2.043B |
| July 22, 2026 | 2.073B |
| July 21, 2026 | 2.114B |
| July 20, 2026 | 2.139B |
| July 17, 2026 | 2.138B |
| July 16, 2026 | 2.170B |
| July 15, 2026 | 2.096B |
| July 14, 2026 | 2.052B |
| July 13, 2026 | 2.107B |
| July 10, 2026 | 2.163B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 74.92B |
| Abbott Laboratories | 205.21B |
| AngioDynamics, Inc. | 600.95M |
| Alphatec Holdings, Inc. | 2.063B |
| AtriCure, Inc. | 2.862B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.05M |
| Revenue (Quarterly) | 70.38M |
| Total Expenses (Quarterly) | 53.33M |
| EPS Diluted (Quarterly) | 0.695 |
| Gross Profit Margin (Quarterly) | 70.12% |
| Profit Margin (Quarterly) | 24.22% |
| Earnings Yield | 3.56% |
| Operating Earnings Yield | 4.13% |
| Normalized Earnings Yield | 3.559 |